Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk

Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk is a topic covered in the EE+ POEM Archive.

To view the entire topic, please sign in or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception

"Snowball fingers" - Image

Botulinum toxin for the treatment of strabismus: Cochrane systematic review

ACC/AHA: Fewer patients require prophylaxis for endocarditis

Citation

Barry, Henry, et al., editors. "Liraglutide Reduces Mortality (NNT = 71) in Patients With T2DM and Very High CV Risk." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk.

Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk. In: Barry H, Ebell MH, Shaughnessy AF, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk. Accessed January 21, 2019.

Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. Available from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk

Liraglutide Reduces Mortality (NNT = 71) in Patients With T2DM and Very High CV Risk [Internet]. In: Barry H, Ebell MH, Shaughnessy AF, Slawson DC, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2019 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case

TY - ELEC T1 - Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk ID - 1314080 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -